Within trial cost-utility analysis of disease management program for patients hospitalised with atrial fibrillation: results from the SAFETY Trial.
Conclusions: Compared with standard management, the SAFETY intervention is potentially a dominant strategy for those with chronic, non-valvular AF. However, there would be substantial value in reducing the uncertainty in these estimates from further research. Trial registration: the Australian New Zealand Clinical Trials Registry (ANZCTRN 12610000221055).
PMID: 31190590 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Atrial Fibrillation | Australia Health | Cardiology | Clinical Trials | Economics | Health Management | Healthcare Costs | Heart | Heart Failure | New Zealand Health | Statistics